Latest news and press releases about Enhabit, Inc. (EHAB): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Enhabit, Inc. operates as a U.S.-based provider of home healthcare and hospice services. Its comprehensive home health division offers various services, such as patient education, pain management, wound care (including dressing changes), cardiac rehabilitation, infusion therapy, pharmaceutical administration, and expert observation and assessment.
Price
| Price | $13.80 |
| Market Cap | $707M |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| Price / Book | 1.28 |
| EV / EBITDA | 18.80 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -0.58% |
| Return on Invested Capital | -1.58% |
| Return on Assets | -0.27% |
| Gross Margin | 47.93% |
| Operating Margin | 7.25% |
| Net Margin | -0.30% |
Related companies: AGL · AUNA · AUTL · CBLL · CCRN · KIDS · LAB
Explore sector: Healthcare · Medical - Care Facilities
More sections of EHAB: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks